Self-control Trial to Evaluate the Role of Aprepitant in the Prophylaxis of Post-lumbar-punture-headache (PLPH)
NCT02347878
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
85
Enrollment
OTHER
Sponsor class
Conditions
Leukemia
Lymphoma
Interventions
DRUG:
Aprepitant
Sponsor
Sun Yat-sen University